In office or At-Home Diabetes Risk Assessment Screening Tests

New Breakthrough for Periodontal Patients
Posted: May 6, 2008

Do Not Take The Risk And Worsen A Periodontal Condition Without Knowing If Your Patient Is A Diabetic
  New Breakthrough for Periodontal Patients—In office or At-Home Diabetes Risk Assessment Screening Tests
 
Many of the 6 million undiagnosed diabetics will visit their dentist more often than their physician and are more prone to have periodontal disease. There are 54 million prediabeteics and every week many unknowingly become diabetics. This first ever FDA approved diabetes risk assessment is a convenient and inexpensive service for the dental office to screen with lab accurate results for diabetes.
 
The BIOSAFE Diabetes Risk Assessment contains 2 tests. Test 1 is an immediate glucose reading.   Test 2 is a mail-in laboratory analysis for hemoglobin A1c, which is a blood glucose marker for the previous ninety-day period.  The samples for both tests use a simple finger-nick collection kit which can be self-collected at home or the 3 drop sample can be taken in the dental office.  The sample for the hemoglobin A1c is mailed to the Biosafe Laboratory. 
 
Taken in combination, these two results become a reliable indicator of diabetes or a pre-diabetes condition.  Results are reported by fax to the dental office and paper mailed to the patient in an easy to understand report to share with the physician for diagnosing.   
 

 
The wholesale cost to dentists is $14.99 Since periodontal disease can elevate glucose levels it is in the scope of dentistry to screen for glucose levels to proply control periodontal disease. Dentists must never diagnose a medical condition.
 
Type 2 diabetes (non-insulin dependent diabetes) affects more than 20 million Americans and is the most common form of the disease.  However, because diabetes exhibits few if any symptoms until its advanced stages, millions more are in danger of contracting the disease and are unaware of it.  When blood glucose (sugar) levels are higher than normal, but not yet high enough to be classified as diabetes, a condition known as pre-diabetes exists.  If discovered early, a person with pre-diabetes can avoid the disease through education, diet, exercise, and drugs. 
 
Diabetes is a debilitating, crippling, and life-shortening disease whose most serious complications can be prevented with early detection. The BIOSAFE Diabetes Risk Assessment is a common-sense approach to early detection of a potentially dangerous condition. Millions of people remain unknowingly undiagnosed and at risk for the disease.  By using this quick, convenient and inexpensive kit, those who are indentified as being in a diabetic or pre-diabetic state can work with their physicians to implement treatment or dietary and healthy lifestyle changes to avoid the onset of diabetes and its catastrophic complications, like heart disease, blindness, and kidney failure.
 
 
For more information visit http://www.Healthyheartdentistry.com
 
 
 
Located in Chicago, Illinois, BIOSAFE Laboratories, Inc. is a subsidiary of BIOSAFE Medical Technologies, Inc. The company develops, manufactures, and processes health monitoring and screening products for the consumer, physician, health screening, occupational health, pharmaceutical, disease-management, and medical research markets. 
Views: 34
Sponsors
Sally Gross, Member Services Specialist
Phone: +1-480-445-9710
Email: sally@farranmedia.com
©2025 Hygienetown, a division of Farran Media • All Rights Reserved
9633 S. 48th Street Suite 200 • Phoenix, AZ 85044 • Phone:+1-480-598-0001 • Fax:+1-480-598-3450